Andere talen Mycenax Biotech Inc.

Aandelen

4726

TW0004726005

slotkoers Taipei Exchange Andere beurzen 00:00:00 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
42,3 ^TWD	-0,47%		-7,34%	+18,49%

14/03	Mycenax Biotech Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
13/03	Mycenax Biotech Inc. kondigt de benoeming aan van Li-Ju Yeh als Corporate Governance Officer	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer	13/03
Mycenax Biotech Inc. cancelled the transaction announced on March 13, 2023	13/03
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	13/03
Mycenax Biotech Inc. Announces Resignation of Stacy Sun as Corporate Governance Officer, Effective on February 29, 2024	27/02
Mycenax Biotech Inc. Announces Board Changes	19/02
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11-08-23
Mycenax Biotech Inc. Announces Resignation of Yu-Ching Chang as Financial and Accounting Officer, Effective on August 11, 2023	02-08-23
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14-03-23
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14-03-23
Mycenax Biotech Inc. announced a financing transaction	13-03-23
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11-11-22
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12-08-22
Mycenax Biotech Inc. announced that it expects to receive TWD 1.659112761 billion in funding from JCR Pharmaceuticals Co., Ltd., Center Laboratories, Inc.	27-07-22
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	14-05-22
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24-03-22
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12-11-21
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14-08-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Mycenax Biotech Inc.

Aandelen

4726

TW0004726005

Andere talen

Filters